Marino, Mariapaola
 Distribuzione geografica
Continente #
NA - Nord America 2.276
EU - Europa 1.703
AS - Asia 943
SA - Sud America 229
AF - Africa 26
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.191
Nazione #
US - Stati Uniti d'America 2.243
SE - Svezia 524
SG - Singapore 372
CN - Cina 307
IT - Italia 292
DE - Germania 252
BR - Brasile 209
FR - Francia 136
IE - Irlanda 128
ID - Indonesia 74
UA - Ucraina 68
IN - India 67
GB - Regno Unito 63
RU - Federazione Russa 59
FI - Finlandia 50
BE - Belgio 27
KR - Corea 27
CA - Canada 22
HK - Hong Kong 22
PL - Polonia 18
AT - Austria 14
NL - Olanda 13
TR - Turchia 12
CH - Svizzera 11
CI - Costa d'Avorio 11
ES - Italia 10
IR - Iran 9
MX - Messico 9
AU - Australia 8
CZ - Repubblica Ceca 7
JP - Giappone 7
UZ - Uzbekistan 7
BD - Bangladesh 5
VN - Vietnam 5
ZA - Sudafrica 5
AR - Argentina 4
BY - Bielorussia 4
IQ - Iraq 4
LT - Lituania 4
MA - Marocco 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AL - Albania 3
BO - Bolivia 3
EC - Ecuador 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
PK - Pakistan 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
GA - Gabon 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PH - Filippine 2
TM - Turkmenistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
CY - Cipro 1
DO - Repubblica Dominicana 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
VE - Venezuela 1
Totale 5.191
Città #
Chandler 532
Ashburn 269
Singapore 253
Dublin 128
San Mateo 89
New York 81
Jakarta 74
Rome 72
North Bergen 57
Marseille 52
Milan 50
Cattolica 49
The Dalles 49
Wilmington 49
Los Angeles 48
Boston 46
Princeton 46
Ann Arbor 45
Moscow 43
Jacksonville 41
Bremen 35
Redwood City 33
Chicago 31
Helsinki 30
Beijing 27
Dearborn 26
Woodbridge 26
Boardman 25
Hefei 25
Nanjing 25
Hyderabad 23
Seoul 23
Brussels 21
Houston 20
Hong Kong 19
São Paulo 19
Bologna 17
Kraków 17
Seattle 17
Frankfurt am Main 16
Munich 16
Falls Church 15
Norwalk 15
Abidjan 11
Falkenstein 11
Nuremberg 11
Des Moines 10
Fairfield 10
Washington 10
Düsseldorf 9
Edinburgh 9
Lawrence 9
Nanchang 9
Toronto 9
Atlanta 8
Hebei 8
Chengdu 7
London 7
Rio de Janeiro 7
San Francisco 7
Zurich 7
Belo Horizonte 6
Hangzhou 6
Izmir 6
Lancaster 6
Lappeenranta 6
San Jose 6
Tashkent 6
Bexley 5
Brno 5
Brooklyn 5
Buffalo 5
Changsha 5
Jiaxing 5
Mountain View 5
Naples 5
Ottawa 5
Sacramento 5
Salvador 5
Shenyang 5
Tokyo 5
Vienna 5
Auckland 4
Augusta 4
Berlin 4
Bern 4
Campo Grande 4
Charlotte 4
Irapuato 4
Kunming 4
Lauterbourg 4
Melbourne 4
Nürnberg 4
Oslo 4
Paris 4
Pune 4
Rabat 4
Santa Clara 4
Shanghai 4
Shenzhen 4
Totale 2.937
Nome #
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 184
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 162
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 146
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 140
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 130
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 127
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 120
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 112
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 108
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 104
Immunological role of IgG subclasses 103
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 101
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 97
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 96
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 91
Skeletal muscle cells: from local inflammatory response to active immunity 88
Myasthenia gravis with antibodies to MuSK: an update 87
Immunological role of IgG subclasses 87
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 86
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 84
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 84
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 83
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 83
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 82
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 82
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 81
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 80
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 80
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 77
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 77
The Laboratory Role in anti-TNF Biological Therapy Era 74
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 73
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 71
Cryoglobulins: putative effectors of adaptive immune response 69
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 69
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 68
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 67
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 66
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 66
IL-6, monocyte infiltration and parenchymal cells 63
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 63
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 62
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 62
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 61
Free light chains and autoimmunity 59
Fluidi ed elettroliti. Equilibrio acido-base 57
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 57
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 57
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 57
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 56
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 55
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 53
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 52
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 48
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 45
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 44
Immune-inflammatory response changes in patients with major depressive disorder 42
The dark side of current analytic methods for Bence Jones Proteinuria 42
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 39
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 39
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 35
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 35
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 34
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 33
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 33
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 32
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 31
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 31
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 30
Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries 28
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 28
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 28
Calprotectin: two sides of the same coin 27
Type 2 cytokines and scleroderma interstitial lung disease 27
Anti-Inflammatory Effects of Curcumin-Based Nanoparticles Containing α-Linolenic Acid in a Model of Psoriasis In Vitro 25
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 24
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 23
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 22
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 22
Totale 5.346
Categoria #
all - tutte 27.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 0 0 0 0 0 46 12
2020/2021259 22 12 3 16 71 16 16 8 22 6 53 14
2021/2022600 24 15 13 63 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/20251.571 75 68 131 66 143 85 51 110 308 157 377 0
Totale 5.346